ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PSCR Proto Script Pharmaceutical Corporation (CE)

0.0002
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Proto Script Pharmaceutical Corporation (CE) USOTC:PSCR OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0002 0.00 01:00:00

Current Report Filing (8-k)

17/06/2016 7:32pm

Edgar (US Regulatory)



SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 16, 2016


YANEX GROUP, INC.

(Exact name of registrant as specified in its charter)

 


Nevada

 

333-175146

 

99-0363803

(State or other jurisdiction

 

(Commission File Number)

 

(IRS Employer

of Incorporation)

 

 

 

Identification Number)

 

 


9830 6 th Street, Suite 103

Rancho Cucamonga, CA 91730

(855) 476-7679

 

 

 (Address, including zip code, and telephone number, including area code,

of registrant's principal executive offices)



18881 Von Karman Ave., Suite 1440

Irvine, CA 92162

(707) 714-1088

 (Former name or former address, if changed since last report.)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

        .  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 


        . Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 


        .  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


        .  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 8.01

OTHER EVENTS.


Effective June 16, 2016, Yanex Group, Inc. (the “Company”) has changed its corporate address to 9830 6 th Street, Suite 103, Rancho Cucamonga, CA, 91730. Our new telephone number is (855) 476-7679.





SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Yanex Group, Inc.



Dated: June 16, 2016

/s/ Leonardo Correa Rodriguez

By: Leonardo Correa Rodriguez

Its: Chief Executive Officer


 



1 Year Proto Script Pharmaceuti... (CE) Chart

1 Year Proto Script Pharmaceuti... (CE) Chart

1 Month Proto Script Pharmaceuti... (CE) Chart

1 Month Proto Script Pharmaceuti... (CE) Chart

Your Recent History

Delayed Upgrade Clock